Somapacitan for treating growth hormone deficiency in people 3 to 17 years

Evaluation committee members

The highly specialised technologies evaluation committee is a standing advisory committee of NICE. This topic was considered as a cost comparison evaluation by the lead team of the highly specialised technologies evaluation committee, which includes the chair and vice chair.

Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that appraisal.

Chair

Paul Arundel
Chair, highly specialised technologies evaluation committee

NICE project team

Each technology appraisal is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the appraisal), a technical adviser and a project manager.

Harsimran Sarpal
Technical lead

Lizzie Walker
Technical adviser

Leena Issa
Project manager

Ian Watson
Associate director

ISBN: 978-1-4731-7030-8